Skip to content

Analgesia for Perineal Surgeries in High-risk Pediatric Patients

Efficacy of Ultrasound-guided Sacral Multifidus Plane Block as Perioperative Analgesia for Anal and Penile Surgeries in High-risk Pediatric Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07602894
Enrollment
60
Registered
2026-05-22
Start date
2026-07-20
Completion date
2027-12-01
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia

Brief summary

Perioperative pain management in pediatric patients, especially for anorectal and penile surgeries, presents significant challenges for anesthetists. Complications associated with systemic analgesia, such as respiratory issues, cardiovascular problems, and neurological effects, can be avoided by using regional anesthesia. This study aims to evaluate the effectiveness of Ultrasound-Guided Sacral Multifidus Plane Block as a method for perioperative analgesia in high-risk pediatric patients undergoing anorectal and penile surgeries, to reduce the risks associated with systemic analgesia.

Detailed description

Effective postoperative pain control in pediatric patients remains a major concern, particularly in those undergoing anal, perineal and penile surgeries. Inadequate analgesia is associated with delayed recovery, increased stress response, prolonged hospitalisation, and higher postoperative morbidity. This study aims to evaluate the efficacy of ultrasound-guided sacral multifidus plane block as a method for perioperative analgesia in high-risk pediatric patients undergoing anorectal and penile surgeries, to reduce the risks associated with systemic analgesia. This involves the administration of local anesthetics in the plane between the sacral multifidus muscle and the intermediate sacral crest bilaterally.

Interventions

Patients will receive 10 milligrams per kilogram body weight of intravenous paracetamol every 8 hours and fentanyl 1 microgram per kilogram body weight intravenously as rescue analgesia.

Patients will receive an ultrasound-guided sacral multifidus plane block after induction of general anesthesia.

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
12 Months to 12 Years
Healthy volunteers
No

Inclusion criteria

* Parents or caregivers' acceptance. * High-risk pediatric patients (the American Society of Anesthesiologists physical status class III-IV) * Body mass index equal to 5%: 85% of the same age and sex.

Exclusion criteria

* Child with a contraindication to the regional block, such as infection at the site of injection, or coagulopathy. * Pre-existing neurological disorders.

Design outcomes

Primary

MeasureTime frameDescription
Time to rescue analgesia24 hoursFirst time of additional analgesia given when the child exhibit moderate to severe pain with pain score become ≥ 4.

Secondary

MeasureTime frameDescription
Heart rate24 hoursThe perioperative changes in heart rate basally and at time interval 10-minutes till discharge and at ward at 2,4,8,16, and 24 hours postoperative.
Mean arterial pressure24 hoursThe perioperative changes in mean blood pressure basally and at time interval 10-minutes till discharge and at ward at 2,4,8,16, and 24 hours postoperative.
Postoperative pain score24 hoursPain score will be assessed using the Face, Legs, Activity, Cry, and Consolability score immediately postoperative then at 2, 4, 8, 16 and 24 hours with a score of 0 indicates no pain and 10 indicates maximum pain.
Total dose of opioid consumption24 hoursThe total dose of opioid consumption as rescue analgesia in the first 24 hours postoperative.
Parental satisfaction24 hoursParental satisfaction will be evaluated using a five-point score at the end of the first 24 hours with a score of 5 indicate the highest satisfaction and 1 indicate the lowest satisfaction.

Countries

Egypt

Contacts

CONTACTAbdalla Mohamed Goda Mohamed, MD
drabdogoda@gmail.com1114166085
CONTACTAmira Attia Ebrahim Farag, MD
Amiraattia86@gmail.com
PRINCIPAL_INVESTIGATORAbdelrazek yousef, MD

Department of Pediatric surgery, Zagazig University

PRINCIPAL_INVESTIGATORMohamed Ismail Sabry, MD

Department of Pediatric surgery, Zagazig University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 25, 2026